A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy.

Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag (2015) 1.01

Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy. J Pain (2016) 0.85

Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study. Support Care Cancer (2015) 0.81

Can Stopping Nerves, Stop Cancer? Trends Neurosci (2016) 0.78

Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats. Sci Rep (2015) 0.77

Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer. Oncology (2016) 0.77

Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain (2015) 0.75

A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises. Exp Hematol Oncol (2017) 0.75

Piezo2 is required for Merkel-cell mechanotransduction. Nature (2014) 2.45

Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain (2004) 2.38

Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills (1993) 2.36

Merkel cells are essential for light-touch responses. Science (2009) 2.24

Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83

A new device to quantify tactile sensation in neuropathy. Neurology (2011) 1.62

Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60

Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain (2010) 1.51

Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain (1978) 1.47

Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp Neurol (2011) 1.27

Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain (2009) 1.21

Secondary hyperalgesia persists in capsaicin desensitized skin. Pain (2000) 1.12

Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemother Pharmacol (2012) 1.08

Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. J Pain (2013) 1.06

Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J Peripher Nerv Syst (2002) 1.06

Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients. J Pain (2011) 1.06

Neurologic complications of cancer and its treatment. Curr Oncol Rep (2010) 0.97

Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells. J Neuroimmunol (2002) 0.89

Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evid Based Complement Alternat Med (2013) 0.88

Glial cells as targets for cytotoxic immune mediators. Glia (2001) 0.88

Merkel Cells in Somatosensation. Chemosens Percept (2008) 0.86

Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res (2012) 0.85

Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol (2013) 0.83

Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. J Clin Oncol (2014) 0.83

Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro. Neurology (1998) 0.82